Tag: Imprimed

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

ImpriMed, a precision medicine startup, has developed AI-powered technology for personalized drug efficacy prediction in canine and feline blood cancers. The company now aims to expand its technology to human oncology applications. ImpriMed recently closed a $23 million Series A funding and has been partners with SK Telecom. Their B2B service involves collecting live cancer […]

©2023 The Horizon